|
DDX19B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.12200004421493E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.79525999999264E-05 |
| Normal-vs-Stage2 |
1.358070E-02 |
| Normal-vs-Stage3 |
1.395610E-03 |
| Normal-vs-Stage4 |
8.584000E-01 |
| Stage1-vs-Stage2 |
9.915200E-01 |
| Stage1-vs-Stage3 |
1.471780E-01 |
| Stage1-vs-Stage4 |
1.793590E-01 |
| Stage2-vs-Stage3 |
2.983400E-01 |
| Stage2-vs-Stage4 |
1.727760E-01 |
| Stage3-vs-Stage4 |
6.708200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.69030000685933E-09 |
| Normal-vs-AfricanAmerican |
5.876800E-03 |
| Normal-vs-Asian |
2.882800E-01 |
| Caucasian-vs-AfricanAmerican |
6.879600E-02 |
| Caucasian-vs-Asian |
7.461600E-01 |
| AfricanAmerican-vs-Asian |
5.292600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.24980000185226E-08 |
| Normal-vs-Female |
2.016200E-04 |
| Male-vs-Female |
6.782200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.353200E-01 |
| Normal-vs-Extreme_Weight |
4.07250000000747E-05 |
| Normal-vs-Obese |
4.43350000001175E-06 |
| Normal-vs-Extreme_Obese |
3.034000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.024500E-02 |
| Normal_Weight-vs-Obese |
1.182250E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.849800E-01 |
| Extreme_Weight-vs-Obese |
4.004400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.394200E-01 |
| Obese-vs-Extreme_Obese |
4.763200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.236000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.24809999949116E-07 |
| Normal-vs-Age(61-80Yrs) |
3.79179999998591E-06 |
| Normal-vs-Age(81-100Yrs) |
1.842430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.170200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.633000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.269400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.177000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.009600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.453600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.43899999980069E-07 |
| Normal-VS-Type2 PRCC |
1.008970E-04 |
| Normal-VS-KIRP CIMP |
8.717900E-02 |
| Normal-VS-Unclassified PRCC |
7.68140000000361E-05 |
| Type1 PRCC-VS-Type2 PRCC |
9.130600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.594600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.216610E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.212000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.801640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.825600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.022600E-03 |
| Normal-vs-N1 |
4.836200E-04 |
| Normal-vs-N2 |
2.926000E-01 |
| N0-vs-N1 |
5.465400E-01 |
| N0-vs-N2 |
1.161600E-01 |
| N1-vs-N2 |
8.624500E-03 |
|
|
